US Stock MarketDetailed Quotes
TAK Takeda Pharmaceutical
- 13.620
- +0.090+0.67%
Close Nov 19 16:00 ET
- 14.190
- +0.570+4.18%
Post 16:31 ET
43.34BMarket Cap23.16P/E (TTM)
13.630High13.531Low1.68MVolume13.560Open13.530Pre Close22.82MTurnover0.06%Turnover Ratio46.17P/E (Static)3.18BShares15.08052wk High0.97P/B41.48BFloat Cap12.57552wk Low0.31Dividend TTM3.05BShs Float20.357Historical High2.26%Div YieldTTM0.73%Amplitude11.568Historical Low13.585Avg Price1Lot Size
About Takeda Pharmaceutical Company
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Company Profile
SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49281
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com
Company Executives
- Name
- Position
- Salary
- Christophe Weber
- Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
- 1.70B
- Akiko Amakawa
- Corporate Strategy Officer and Chief Executive Officer Chief of Staff
- --
- Gabriele Ricci
- Chief Data and Technology Officer
- --
- Mwana Lugogo
- Chief Ethics and Compliance Officer
- --
- Lauren Duprey
- Chief Human Resources Officer
- --
- Takako Ohyabu
- Chief Global Corporate Affairs and Sustainability Officer
- --
- Milano Furuta
- Director and Chief Financial Officer
- --
- Marcello Agosti
- Global Business Development Officer
- --
- Elaine Shannon
- Global Quality Officer
- --
- Dr. Thomas Wozniewski, PhD
- Global Manufacturing and Supply Officer
- --
- Teresa Marie Bitetti
- President, Global Oncology Business Unit
- --
- Asuka Miyabashira
- President, Japan Pharma Business Unit
- --
- Julie Kim
- President, U.S. Business Unit and U.S. Country Head
- --
- Giles Platford
- President, Plasma-Derived Therapies Business Unit
- --
- Masami Iijima
- Chairman of the Board
- 43.00M
- Andrew S. Plump, M.D.
- Director and President, Research and Development
- 12.00M
- Ramona Sequeira
- President, Global Portfolio Division
- --
- Kimberly A. Reed
- Independent Director
- 41.00M
- Yoshiaki Fujimori
- Independent Director
- 40.00M
- Dr. John M. Maraganore,PhD
- Independent Director
- 39.00M
- Koji Hatsukawa
- Independent Director
- 43.00M
- Ian T. Clark
- Independent Director
- 44.00M
- Miki Tsusaka
- Independent Director
- 32.00M
- Michel Orsinger
- Independent Director
- 46.00M
- Dr. Steven Gillis, Pd.D
- Independent Director
- 44.00M
- Jean-Luc Butel
- Independent Director
- 38.00M
- Emiko Higashi
- Independent Director
- 49.00M
- Yoshihiro Nakagawa
- Global General Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
